Roche discontinues low dose in Huntington’s trial
19 Apr 2025 //
ENDPTS
Ionis` partner to evaluate tominersen for Huntington`s disease in Phase 2 trial
18 Jan 2022 //
PRNEWSWIRE
Pathbreaking` Ionis trial offers way forward in Huntington`s disease
07 May 2019 //
BIOPHARMADIVE

Market Place
Sourcing Support